600763.SS SHH
Topchoice Medical Corporation
1W: +1.0%
1M: -1.2%
3M: -3.7%
YTD: -29.9%
1Y: -24.8%
3Y: -52.5%
5Y: -86.5%
¥34.07 ($5.08)
+1.07 (+3.24%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$2.9B
+1.0% ▲
5Y CAGR: +8.3%
Gross Profit
$1.1B
+0.9% ▲
5Y CAGR: +4.7%
Operating Income
$699M
-1.9% ▼
5Y CAGR: +1.8%
Net Income
$501M
+0.2% ▲
5Y CAGR: +1.5%
EPS (Diluted)
$1.12
+0.0% ▲
5Y CAGR: +1.5%
EBITDA
$779M
-0.0% ▼
5Y CAGR: +2.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $2.1B | $2.8B | $2.7B | $2.8B | $2.9B |
| YoY Growth | +8.1% | +33.2% | -2.2% | +4.7% | +1.0% |
| Cost of Revenue | $1.1B | $1.5B | $1.6B | $1.7B | $1.8B |
| Gross Profit | $943M | $1.3B | $1.1B | $1.1B | $1.1B |
| Gross Margin | 45.2% | 46.1% | 40.8% | 38.5% | 38.5% |
| R&D Expenses | $40M | $59M | $54M | $56M | $59M |
| SG&A Expenses | $248M | $283M | $313M | $338M | $348M |
| Operating Expenses | $264M | $306M | $376M | $385M | $408M |
| Operating Income | $679M | $975M | $734M | $712M | $699M |
| Operating Margin | 32.5% | 35.1% | 27.0% | 25.0% | 24.3% |
| Interest Expense | $23M | $35M | $56M | $61M | $52M |
| Income Before Tax | $680M | $975M | $738M | $709M | $694M |
| Tax Expense | $135M | $188M | $122M | $130M | $122M |
| Net Income | $493M | $703M | $548M | $500M | $501M |
| Net Margin | 23.6% | 25.3% | 20.2% | 17.6% | 17.4% |
| EPS (Diluted) | $1.10 | $1.56 | $1.22 | $1.12 | $1.12 |
| EBITDA | $713M | $1.0B | $817M | $780M | $779M |
| Shares Outstanding | 321M | 321M | 320M | 320M | 448M |